Working… Menu
Trial record 1 of 1 for:    NCT04596488
Previous Study | Return to List | Next Study

Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04596488
Recruitment Status : Completed
First Posted : October 22, 2020
Last Update Posted : October 23, 2020
National Key Technologies R&D Program for the 13th Five-year Plan
National Key Technologies R&D Program for the 12th Five-year Plan
CAMS Initiative for Innovative Medicine
Information provided by (Responsible Party):
LI Taisheng, Peking Union Medical College Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 30, 2018
Actual Study Completion Date : December 30, 2019